최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of Korean Medicine = 대한한의학회지, v.42 no.1, 2021년, pp.119 - 128
방선휘 (휘림한방병원) , 윤영주 (부산대학교 한의학전문대학원) , 최준용 (부산대학교 한의학전문대학원) , 한창우 (부산대학교 한의학전문대학원) , 김소연 (부산대학교 한의학전문대학원) , 박성하 (부산대학교 한의학전문대학원) , 홍진우 (부산대학교 한의학전문대학원) , 권정남 (부산대학교 한의학전문대학원) , 이인 (부산대학교 한의학전문대학원)
비소세포성폐암 3기B 진단을 받고, 표준치료인 동시항암방사선치료를 시행했으나 별무효과였던 40대 남자에게, 한양방통합치료를 장기간 집중적으로 시행한 결과, 3개월만에 완전 관해에 도달하고, 5년 생존에 성공함으로써 한양방통합치료의 가능성을 보여 주었기에, 이에 증례를 보고한다.
Objectives: This is a five-year survival case report on non-small cell lung cancer (NSCLC) treated with western medicine and traditional Korean medicine. 44-year old man diagnosed NSCLC IIIB in 2015 went through two months' concurrent chemoradiotherapy (CCRT) first, however the cancer did not respon...
Annual Report of national cancer statistics in Korea in 2017. National Cancer Center. 2019.
Jeong SH, Jung JH, Lee HW, Kang SY, choi YW, Ahn MS, et al. Concurrent Chemoradiotherapy with Weekly Paclitaxel for Locally Advanced Non-small Cell Lung Cancer. J Lung Cancer. 2009;8(1);8-12.
Wu X, Chung VC, Lu P, Poon SK, Hui EP, Lau AY, et al. Chinese Herbal Medicine for Improving Quality of Life Among Nonsmall Cell Lung Cancer Patients: Overvies of Systematic Reviews and Network Meta-Analysis. Medicine. 2016;95(1):e2410.
Liu J, Lin HS, Hou W, Hua BJ, Zhang PT, Li J, et al. Comprehensive treatment with Chinese medicine in patients with advanced non-small cell lung cancer: A multicenter, prospective, cohort study. Chin J Integr Med. 2017;23(10):733-739.
Kin KS. Case Study: Regression of a residual tumor and prolongation of overall survival with allergen-removed Rhus Verniciflua stokes after chemoradiotherapy in locally advanced non-small cell lung cancer. J Int Korean Med.2015;36(2):200-206.
Zheng HM, Yoon JW, Lee YW, Cho CK, Ph DS, Yoo HS. Case Series of advanced non-small cell lung cancer patients treated with Hang-am Plus. J Int Korean Med. 2011;32(1):113-120.
Park JG, Bang YJ, Ha SH. Oncology. 2nd rev. ed. Seoul:Iljogak. 2012:224-239.
NCCN clinical practice guidelines in oncology (ver.8). National Comprehensive cancer network. 2020.
Costa GJ, Ferreira CG, Thuler CS. Concurrent chemoradiotherapy for stage III non-small cell lung cancer: corredt clinical management as the basis to move beyond, Ann Transl Med. 2018;6(Suppl 1):S65.
Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002;3(8):487-497.
Garaci E, Pica F, Matteucci C, Gaziano R, D'Agostini C, Miele MT, et al. Historical review on thymosin α1 in oncology: preclinical and clinical experiences. Expert Opin Biol Ther. 2015;15(Suppl 1):S31-9.
Fritz H, Flower G, Weeks L, Cooley K, Callachan M, McGowan J, et al, Intravenous Vitamin C and Cancer: A Systematic Review. Integr Cancer Ther. 2014 Jul;13(4):280-300.
Kwon KR, Kim HD, Kim JS, Yoo HS, Cho CK. Case series of Non-small cell Lung cancer treated with mountain Ginseng pharmacopuncture. J Acupunct Meridian Stud. 2011;4(11):61-68.
Dai D, Zhang CF, Williams S, Yuan CS, Wang CZ. Ginseng on Cancer: Potential Role in Modulating Inflammation-Mediated Angiogenesis. Am J Chin Med. 2017;45(1): 13-22.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.